These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 3435068)
1. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies. Mouradian MM; Juncos JL; Fabbrini G; Chase TN Ann Neurol; 1987 Oct; 22(4):475-9. PubMed ID: 3435068 [TBL] [Abstract][Full Text] [Related]
2. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease. Fabbrini G; Juncos J; Mouradian MM; Serrati C; Chase TN Ann Neurol; 1987 Apr; 21(4):370-6. PubMed ID: 3579222 [TBL] [Abstract][Full Text] [Related]
3. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I. Fabbrini G; Mouradian MM; Juncos JL; Schlegel J; Mohr E; Chase TN Ann Neurol; 1988 Sep; 24(3):366-71. PubMed ID: 3228270 [TBL] [Abstract][Full Text] [Related]
4. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II. Mouradian MM; Juncos JL; Fabbrini G; Schlegel J; Bartko JJ; Chase TN Ann Neurol; 1988 Sep; 24(3):372-8. PubMed ID: 3228271 [TBL] [Abstract][Full Text] [Related]
5. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations. Sage JI; Mark MH Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688 [TBL] [Abstract][Full Text] [Related]
6. Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms. Bravi D; Mouradian MM; Roberts JW; Davis TL; Sohn YH; Chase TN Ann Neurol; 1994 Jul; 36(1):27-31. PubMed ID: 8024257 [TBL] [Abstract][Full Text] [Related]
7. Pathogenetic studies of motor fluctuations in Parkinson's disease. Chase TN; Mouradian MM; Fabbrini G; Juncos JL J Neural Transm Suppl; 1988; 27():3-10. PubMed ID: 3042912 [TBL] [Abstract][Full Text] [Related]
8. [Changes in the nigrostriatal dopamine receptor compartment after continuous dopaminergic infusions in Parkinson disease]. Baronti F; Ruggieri S; Mouradian MM; Bonamartini A; Bocciarelli P; De Pandis MF; Chase TN; Agnoli A Riv Neurol; 1991; 61(6):210-4. PubMed ID: 1813972 [TBL] [Abstract][Full Text] [Related]
9. Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease. Mouradian MM; Heuser IJ; Baronti F; Chase TN Ann Neurol; 1990 Jan; 27(1):18-23. PubMed ID: 2301923 [TBL] [Abstract][Full Text] [Related]
10. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model. de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500 [TBL] [Abstract][Full Text] [Related]
11. [A new levodopa benserazide preparation for Parkinson's disease with motor fluctuations refractory to standard L-dopa]. Fernández Pardal MM; Gatto E; Micheli F; Casas Parera I; Diaz S Medicina (B Aires); 1991; 51(6):561-7. PubMed ID: 7476112 [TBL] [Abstract][Full Text] [Related]
13. Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease. Nutt JG; Carter JH; Lea ES; Woodward WR Mov Disord; 1997 May; 12(3):285-92. PubMed ID: 9159720 [TBL] [Abstract][Full Text] [Related]
14. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease. McColl CD; Reardon KA; Shiff M; Kempster PA Mov Disord; 2002 Nov; 17(6):1227-34. PubMed ID: 12465061 [TBL] [Abstract][Full Text] [Related]
15. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage. Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575 [TBL] [Abstract][Full Text] [Related]
16. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients]. Hironishi M; Miwa H; Kondo T No To Shinkei; 2002 Feb; 54(2):127-32. PubMed ID: 11889758 [TBL] [Abstract][Full Text] [Related]
17. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias. Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640 [TBL] [Abstract][Full Text] [Related]
18. [Motor complications in patients with Parkinson disease treated with levodopa]. Luquin MR; Obeso JA; Martínez-Lage JM Neurologia; 1989; 4(1):4-11. PubMed ID: 2631806 [TBL] [Abstract][Full Text] [Related]
19. Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuations. Poewe WH; Lees AJ; Stern GM Eur Neurol; 1987; 27 Suppl 1():93-7. PubMed ID: 3322842 [TBL] [Abstract][Full Text] [Related]
20. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A; Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]